Dendritic cell therapy for oncology roundtable conference.

about

Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.Detection of Bovine IgG Isotypes in a PPA-ELISA for Johne's Disease Diagnosis in Infected Herds

P2860

Q34032559-5FD4C338-2655-4E02-AE40-28993F87C0BA Q41957094-D1827ECD-FBD1-4FAA-AB9E-FA53FF5E88A8

P2860

Dendritic cell therapy for oncology roundtable conference.

Item

http://www.wikidata.org/entity/Q39794478

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Dendritic cell therapy for oncology roundtable conference.

@en

Dendritic cell therapy for oncology roundtable conference.

@nl

type

Item

label

Dendritic cell therapy for oncology roundtable conference.

@en

Dendritic cell therapy for oncology roundtable conference.

@nl

prefLabel

Dendritic cell therapy for oncology roundtable conference.

@en

Dendritic cell therapy for oncology roundtable conference.

@nl

P1476

Dendritic cell therapy for oncology roundtable conference

@en

P2093

Sandra Tuyaerts

http://www.w3.org/2001/XMLSchema#string

P2860

Improved endpoints for cancer immunotherapy trials

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters.

Antigens for cancer immunotherapy.

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer.

P2888

1476-8518-9-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-8518-9-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sandra Tuyaerts

P577

2011-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49747619

http://www.w3.org/2001/XMLSchema#string

P6179

1042606573

http://www.w3.org/2001/XMLSchema#string

P698

21226916

http://www.w3.org/2001/XMLSchema#string

P932

3027086

http://www.w3.org/2001/XMLSchema#string

Dendritic cell therapy for oncology roundtable conference.

about

P2860

P2860

Dendritic cell therapy for oncology roundtable conference.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932